CDK12 controls transcription at damaged genes and prevents MYC-induced transcription-replication conflicts

Nat Commun. 2024 Aug 18;15(1):7100. doi: 10.1038/s41467-024-51229-5.

Abstract

The identification of genes involved in replicative stress is key to understanding cancer evolution and to identify therapeutic targets. Here, we show that CDK12 prevents transcription-replication conflicts (TRCs) and the activation of cytotoxic replicative stress upon deregulation of the MYC oncogene. CDK12 was recruited at damaged genes by PARP-dependent DDR-signaling and elongation-competent RNAPII, to repress transcription. Either loss or chemical inhibition of CDK12 led to DDR-resistant transcription of damaged genes. Loss of CDK12 exacerbated TRCs in MYC-overexpressing cells and led to the accumulation of double-strand DNA breaks, occurring between co-directional early-replicating regions and transcribed genes. Overall, our data demonstrate that CDK12 protects genome integrity by repressing transcription of damaged genes, which is required for proper resolution of DSBs at oncogene-induced TRCs. This provides a rationale that explains both how CDK12 deficiency can promote tandem duplications of early-replicated regions during tumor evolution, and how CDK12 targeting can exacerbate replicative-stress in tumors.

MeSH terms

  • Cell Line, Tumor
  • Cyclin-Dependent Kinases* / genetics
  • Cyclin-Dependent Kinases* / metabolism
  • DNA Breaks, Double-Stranded
  • DNA Damage
  • DNA Replication*
  • Humans
  • Proto-Oncogene Proteins c-myc / genetics
  • Proto-Oncogene Proteins c-myc / metabolism
  • RNA Polymerase II / genetics
  • RNA Polymerase II / metabolism
  • Transcription, Genetic*

Substances

  • CDK12 protein, human
  • Cyclin-Dependent Kinases
  • Proto-Oncogene Proteins c-myc
  • RNA Polymerase II